Questex's Fierce Life Sciences division has released the agenda for its 2026 Partnerships with Sites Summit, a one-day convening focused on site-driven strategies to improve clinical trial enrollment and participant retention. While the event draws broadly from the life sciences sector, its programming carries direct relevance for functional food and dietary supplement brands navigating the evidence-generation pipeline required to support structure-function claims and, increasingly, substantiated health messaging on finished formulations.
Enrollment and retention failures remain among the most cited reasons clinical studies supporting nutraceutical ingredients fail to reach statistical significance or peer-reviewed publication. For ingredient suppliers and branded manufacturers investing in double-blind, placebo-controlled trials — whether to validate a standardized extract, establish a clinically effective dose in mg/serving, or hit a defined clinical endpoint — site performance is a foundational variable. Poorly retained cohorts compress statistical power and can invalidate otherwise well-designed protocols before a single data point reaches a journal.
The functional ingredients category has seen a marked uptick in clinical investment over the past several years, with brands in gut health, cognitive performance, and sports nutrition commissioning trials to differentiate commoditized ingredient decks. Categories such as probiotics and postbiotics and adaptogenic botanicals have been especially active, as CFU-count competition and ashwagandha market crowding push suppliers toward clinical differentiation. Against that backdrop, summit sessions addressing investigator site engagement, protocol design for retention, and patient recruitment technology are operationally material for nutraceutical R&D teams.
Operator commentary from previous Fierce Life Sciences events has highlighted a persistent gap between pharma-grade trial infrastructure and the comparatively lean budgets functional ingredient companies bring to human substantiation. Speakers at the 2026 summit are expected to address scalable site engagement models that may help bridge that divide, including decentralized trial designs that reduce participant burden — a format increasingly adopted by supplement clinical research organizations serving the nutraceutical space.
The summit is scheduled as a single-day format, details on location and registration are available through Questex's Fierce Life Sciences platform. Brands and ingredient suppliers evaluating clinical investment as part of a 2026 or 2027 regulatory and marketing strategy may find the site-partnership frameworks discussed applicable well beyond the pharmaceutical context in which they were developed.
Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.